IL69917A - Beta-lactam derivatives - Google Patents

Beta-lactam derivatives

Info

Publication number
IL69917A
IL69917A IL69917A IL6991783A IL69917A IL 69917 A IL69917 A IL 69917A IL 69917 A IL69917 A IL 69917A IL 6991783 A IL6991783 A IL 6991783A IL 69917 A IL69917 A IL 69917A
Authority
IL
Israel
Prior art keywords
beta
lactam derivatives
lactam
derivatives
Prior art date
Application number
IL69917A
Other versions
IL69917A0 (en
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IL69917A0 publication Critical patent/IL69917A0/en
Priority to IL79981A priority Critical patent/IL79981A0/en
Publication of IL69917A publication Critical patent/IL69917A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
IL69917A 1982-10-06 1983-10-06 Beta-lactam derivatives IL69917A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL79981A IL79981A0 (en) 1982-10-06 1986-09-09 Beta-lactam derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43317582A 1982-10-06 1982-10-06

Publications (2)

Publication Number Publication Date
IL69917A0 IL69917A0 (en) 1984-01-31
IL69917A true IL69917A (en) 1987-10-20

Family

ID=23719123

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69917A IL69917A (en) 1982-10-06 1983-10-06 Beta-lactam derivatives

Country Status (27)

Country Link
JP (1) JPS5988462A (en)
KR (1) KR900005132B1 (en)
AU (1) AU568312B2 (en)
BE (1) BE897883A (en)
CA (1) CA1253501A (en)
CH (1) CH658858A5 (en)
DD (1) DD222016A5 (en)
DE (1) DE3336262A1 (en)
DK (1) DK457983A (en)
ES (1) ES8504814A1 (en)
FI (1) FI833631A (en)
FR (1) FR2534253B1 (en)
GB (1) GB2129428B (en)
GR (1) GR79704B (en)
HU (1) HU190507B (en)
IE (1) IE56600B1 (en)
IL (1) IL69917A (en)
IT (1) IT1171722B (en)
LU (1) LU85033A1 (en)
NL (1) NL8303410A (en)
NO (1) NO833626L (en)
NZ (1) NZ205642A (en)
PH (1) PH24175A (en)
PT (1) PT77458B (en)
SE (1) SE8305509L (en)
SU (1) SU1318146A3 (en)
ZA (1) ZA837491B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004876A1 (en) * 1984-04-24 1985-11-07 Takeda Chemical Industries, Ltd. 2-azetidinone derivatives and process for their preparation
EP0135194A1 (en) * 1983-09-16 1985-03-27 Takeda Chemical Industries, Ltd. Azetidinones and their production
US4581170A (en) * 1984-08-03 1986-04-08 E. R. Squibb & Sons, Inc. N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
DE3588039T2 (en) * 1984-08-06 1995-11-16 Fujisawa Pharmaceutical Co Azetidinone derivatives and process for their preparation.
UY34585A (en) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg B-LACTAMIC COMPOUNDS REPLACED WITH AMIDINE, ITS PREPARATION AND USE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates

Also Published As

Publication number Publication date
FI833631A0 (en) 1983-10-06
NO833626L (en) 1984-04-09
AU568312B2 (en) 1987-12-24
GB8326626D0 (en) 1983-11-09
LU85033A1 (en) 1984-05-10
GR79704B (en) 1984-10-31
KR840006337A (en) 1984-11-29
AU1993983A (en) 1984-04-12
SE8305509D0 (en) 1983-10-06
IL69917A0 (en) 1984-01-31
IE832354L (en) 1984-04-06
IT8323172A0 (en) 1983-10-06
PH24175A (en) 1990-03-22
BE897883A (en) 1984-03-30
JPS5988462A (en) 1984-05-22
FR2534253A1 (en) 1984-04-13
NZ205642A (en) 1986-08-08
DK457983A (en) 1984-04-07
CH658858A5 (en) 1986-12-15
FI833631A (en) 1984-04-07
PT77458A (en) 1983-11-01
GB2129428B (en) 1986-03-19
HU190507B (en) 1986-09-29
KR900005132B1 (en) 1990-07-20
DE3336262A1 (en) 1984-04-12
DD222016A5 (en) 1985-05-08
GB2129428A (en) 1984-05-16
NL8303410A (en) 1984-05-01
PT77458B (en) 1986-02-26
DK457983D0 (en) 1983-10-04
SE8305509L (en) 1984-04-07
ES526282A0 (en) 1985-04-16
ES8504814A1 (en) 1985-04-16
CA1253501A (en) 1989-05-02
ZA837491B (en) 1984-06-27
IT1171722B (en) 1987-06-10
IE56600B1 (en) 1991-10-09
FR2534253B1 (en) 1985-07-26
SU1318146A3 (en) 1987-06-15

Similar Documents

Publication Publication Date Title
GB8300400D0 (en) 5-methylthiopyrimidine derivatives
GB2117770B (en) Cephalosporin derivatives
GB2128188B (en) Propynylaminoisoxazole derivatives
EP0096296A3 (en) 1-sulfo-2-oxoazetidine derivatives
GB2116180B (en) Cephalosporin derivatives
EP0100250A3 (en) Methylflavone derivatives
GB2132617B (en) Propynlaminothiazole derivatives
GB8309422D0 (en) Substituted penem derivatives
DE3368638D1 (en) Cephalosporin derivatives
GB8313399D0 (en) Penem derivatives
GB2123815B (en) Aletheine derivatives
GB2131803B (en) Oxacephalosporin derivatives
IL69917A (en) Beta-lactam derivatives
ZA832360B (en) Beta-lactam derivatives
GB2116170B (en) 23-0-acyl-23-demycinosyldesmycosin derivatives
GB2121786B (en) 23-demycinosyldesmycosin derivatives
DE3380813D1 (en) Cephalosporin derivatives
ZA823535B (en) Beta-lactam derivatives
DE3379404D1 (en) Cephalosporin derivatives
GB2116176B (en) 3-azetidinylethyl-1-phenyl-2-imidazolidinone derivatives
GB2116545B (en) 23-0-substituted carbamoyl-23-demycinosyldesmycosin derivatives
DE3372207D1 (en) Amino-polyol derivatives
GB2124216B (en) Eburnane derivatives
GB2124215B (en) Eburnane-oxime derivatives
EP0097280A3 (en) Azolyl-substituted oximino-cyano-acetamide derivatives